SCHEMBL7066080

SCHEMBL7066080

CC(=O)C(Cc1ccccc1OCc1cnc2ccccc2c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
STAT3 P40763 1/20 0.41
PDE10A Q9Y233 5/20 0.41
TPH1 P17752 1/20 0.41
SCN9A Q15858 1/20 0.40
NOTUM Q6P988 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
PTGER1 P34995 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGER3 P43115 1/20 0.40
PTGER2 P43116 1/20 0.40
MME P08473 1/20 0.39
ACE P12821 1/20 0.39
CPA1 P15085 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
MGAM O43451 1/20 0.39
CGAS Q8N884 1/20 0.39
FAAH O00519 1/20 0.39
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069548 0.95 PDE10A (0.42) SMN1; SMN2HTTSTAT3PDE10ASCN9A
SCHEMBL7604848 0.93 MGAM (0.43) SMN1; SMN2HTTSTAT3PDE10ATPH1
SCHEMBL7065961 0.89 MME (0.40) SMN1; SMN2HTTSTAT3PDE10ATPH1
SCHEMBL7067687 0.86 MGAM (0.41) SMN1; SMN2HTTSTAT3PDE10ATPH1
SCHEMBL7068772 0.86 PDE10A (0.42) SMN1; SMN2HTTSTAT3PDE10ASCN9A
SCHEMBL7067709 0.86 MEN1 (0.41) PDE10ASCN9ASIRT2MMEACE
SCHEMBL7065979 0.85 MME (0.42) SMN1; SMN2HTTSTAT3PDE10ATPH1
SCHEMBL7069751 0.84 SCN9A (0.45) SMN1; SMN2HTTSTAT3PDE10ATPH1
SCHEMBL7069282 0.84 PPARG (0.45) SMN1; SMN2HTTSTAT3PDE10ASCN9A
SCHEMBL7066077 0.83 MAOB (0.47) TPH1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA SMN1; SMN2 3691/4885HTT 1453/4885STAT3 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.